Galapagos News

Galapagos Analyst Ratings

BenzingaApr 23 01:22

Galapagos Analyst Ratings

BenzingaApr 1 19:06

B of A Securities Downgrades Galapagos to Underperform, Lowers Price Target to $31

BenzingaApr 1 19:07

B of A Securities Downgrades Galapagos to Underperform, Lowers Price Target to $31

BenzingaMar 28 18:20

Galapagos Analyst Ratings

BenzingaMar 28 18:18

Galapagos Analyst Ratings

BenzingaMar 7 17:17

Morgan Stanley Assumes Galapagos at Equal-Weight, Announces Price Target of $38

BenzingaMar 7 17:20

Galapagos (GLPG) Gets a Hold From RBC Capital

TipRanksFeb 27 09:45

TD Cowen Sticks to Their Buy Rating for Galapagos (GLPG)

TipRanksFeb 24 03:25

B of A Securities Maintains Neutral on Galapagos, Raises Price Target to $44

BenzingaJan 3 00:03

Galapagos Analyst Ratings

BenzingaJan 3 00:02

JPMorgan Cuts Galapagos Price Target to $37 From $45, Maintains Neutral Rating

MT NewswiresDec 5, 2023 21:29

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Andlauer Healthcare Group (OtherANDHF) and MoonLake Immunotherapeutics (MLTX)

TipRanksNov 6, 2023 20:14

TD Cowen Keeps Their Buy Rating on Galapagos (GLPG)

TipRanksNov 4, 2023 04:06

Analysts Conflicted on These Healthcare Names: Galapagos (GLPG) and Immunocore Holdings (IMCR)

TipRanksAug 22, 2023 11:40

Analysts' Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP) and Galapagos (GLPG)

TipRanksAug 14, 2023 22:30

Morgan Stanley Maintains Equal-Weight on Galapagos, Lowers Price Target to $40

BenzingaAug 7, 2023 23:29

Galapagos Analyst Ratings

BenzingaAug 7, 2023 23:28

Morgan Stanley Reaffirms Their Hold Rating on Galapagos (GLPG)

TipRanksAug 7, 2023 22:45

RBC Cuts Price Target on Galapagos to $38 From $41, Keeps Sector Perform Rating

MT NewswiresAug 7, 2023 19:41